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Summary
Follicular dendritic cells (FDC) are important stromal cells within the
B-cell follicles and germinal centres (GC) of secondary lymphoid tissues.
FDC trap and retain native antigens on their surfaces in the form of
immune complexes that they display to B cells, in order to select those
cells with the highest antigen affinity. MicroRNAs are short, non-coding
RNAs that are approximately 18–25 nucleotides in length that regulate
gene expression at the post-transcriptional level by repressing the transla-
tion of target genes. In the current study, in vivo and in vitro systems
were used to identify microRNAs that were potentially expressed by FDC.
Constitutive lymphotoxin-b receptor (LTbR) stimulation is required to
maintain FDC in their differentiated state. We show that the rapid de-dif-
ferentiation of spleen FDC that accompanied LTbR-blockade, coincided
with a significant decrease in the expression of mmu-miR-100-5p,
mmu-miR-138-5p and mmu-miR-2137. These microRNAs were shown to
be expressed in the FDC-like cell line, FL-YB, and specific inhibition of
mmu-miR-100-5p significantly enhanced expression of Il6, Ptgs1/2 and
Tlr4 mRNA in this cell line. The expression of Il6, Ptgs1/2 and Tlr4 by
FDC play important roles in regulating GC size and promoting
high-affinity antibody responses, so it is plausible that mmu-miR-
100-5p may help to regulate the expression of these genes during GC
reactions.
Keywords: follicular dendritic cell; microRNA; mmu-miR-100-5p; mRNA;
spleen
Introduction
Follicular dendritic cells (FDC) are a unique population
of non-migratory, non-phagocytic stromal cells.1–3 These
cells have long dendrites that are used to form large net-
works within the B-cell follicles and germinal centres
(GC) of secondary lymphoid tissues such as the spleen
and lymph nodes. FDC express complement receptors
(CR; CR1/CD35 and CR2/CD21) and immunoglobulin
Fc receptors (e.g. FccRIIb), which they use to capture
antigen in the form of immune complexes (antigen–anti-
body and/or opsonizing complement components) on
their surfaces.4 Antigens are retained on FDC in a native
state for long periods of time to promote immunoglobu-
lin-isotype class switching, the positive selection of B
cells with high antigen affinity and the maintenance of
immunological memory.5,6 The up-regulation of adhe-
sion molecules by FDC further facilitates interactions
between B cells and the FDC-retained antigens.7 The
competitive binding of antigen on the FDC surface in
the GC allows those B cells with the highest specific anti-
gen affinity to receive pro-survival signals from FDC via
Abbreviations: CR, complement receptor; FDC, follicular dendritic cell; GC, germinal centre; IL, interleukin; LNA, locked nucleic
acid; LT, lymphotoxin; LTbR, lymphotoxin b receptor; mAb, monoclonal antibody; MFGE8, milk fat globule epidermal growth
factor-like factor 8; TLR4, Toll-like receptor 4; TNF, tumour necrosis factor; WT, wild-type
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cytokines such as interleukin-6 (IL-6) and IL-15, whereas
those with low antigen affinity are targeted for their
clearance via apoptosis.8,9 In addition, FDC also secrete
the chemokine CXCL13, which stimulates the chemotaxis
of CXCR5-expressing B cells into follicles and GC.10,11
The secretion of milk fat globule epidermal growth fac-
tor-like factor 8 (MFGE8) by FDC mediates the engulf-
ment of apoptotic B cells within the GC by tingible body
macrophages.8
In the secondary lymphoid tissues FDC develop from
precursors cells surrounding the blood vessels and they
require further stimulation from lymphoid tissue inducer
cells and lymphotoxin (LT) for expansion.2 FDC and
their precursor cells express the LTb receptor (LTbR) and
stimulation through this receptor by B-cell-derived
LTa1b2 maintains FDC in their differentiated state. In the
absence of constitutive LTbR-mediated stimulation FDC
rapidly de-differentiate.12,13
MicroRNAs are short, non-coding RNA species,
approximately 18–25 nucleotides in length, that act by
targeting partially complementary sequences within
mRNAs and most commonly lead to translational repres-
sion and/or degradation of the target mRNAs.14 There are
over 1000 different microRNAs expressed in human tis-
sues and each microRNA is thought to target hundreds
of genes. Consequently, microRNAs are predicted to reg-
ulate the activity of approximately 50% of all known pro-
tein-coding genes in mammals. MicroRNAs are most
commonly transcribed as independent genes or from pro-
tein-coding genes, and microRNA genes may be clustered
within specific genomic regions.14 MicroRNA transcripts
are processed into stem-loop microRNA precursors by
the RNAse III endonuclease DROSHA, and then exported
to the cytoplasm where a second endonuclease, Dicer,
cleaves the pre-microRNA into the mature form. Mature
microRNAs are assembled into ribonucleoprotein com-
plexes where they interact with specific mRNA targets.
MicroRNAs are often transcribed in a tissue-specific and
developmental stage-specific manner,15 and a small num-
ber have been described as master regulators of develop-
mental processes.
Abundant expression of microRNAs has been
described in many immune cell populations and has
been shown to be involved in the regulation of a number
of immune functions.16–18 For example, studies in mice
show that within the GC microRNAs play a role in the
regulation of gene expression by B cells and follicular
helper T cells.19 Although available data suggest that
human FDC-like cells (HK cells) may induce the expres-
sion of certain microRNAs in GC B cells to promote
survival,20 information on the expression of microRNAs
by FDC has not previously been reported. Similarly,
nothing was known of the effects of LTbR stimulation
on microRNA expression in the spleen. Therefore, in the
current study in vivo and in vitro systems were used to
identify potential microRNAs that may modulate gene
expression in FDC.
Materials and methods
Mice
Lymphotoxin-b-deficient (LTb/) mice21 were obtained
from B & K Universal Ltd (Hull, UK) and were
maintained on a C57BL/6 background. Age-matched
(5–7 weeks old) C57BL/6 mice were used as wild-type
(WT) controls. Mice were housed under specific patho-
gen-free conditions with a 12-hr light/dark cycle and food
and water were provided ad libitum. All experiments were
conducted under the provisions of the UK Animals Scien-
tific Procedures Act 1986 and approved by the University
of Edinburgh’s Ethical Review Committee.
In vivo LTbR blockade
Where indicated, C57BL/6 mice were given a single intra-
venous injection of 100 lg of a fusion protein comprising
the soluble LTbR domain linked to the Fc portion of
human IgG1 (LTbR-Ig)22 to temporarily deplete their
FDC.12,13
Immunohistochemistry
Spleens were removed and divided into two approxi-
mately equal portions. One portion was used to generate
RNA for downstream analyses, while the other was pro-
cessed for histological analyses. Serial frozen sections
(8 lm in thickness) were cut on a cryostat and immuno-
stained with the following antibodies: FDC were visual-
ized by staining with rat anti-CD35/CR1 monoclonal
antibody (mAb) (clone 8C12; BD Biosciences PharMin-
gen, Oxford, UK) or rat anti-MFGE8 mAb (clone FDC-
M1; BD Biosciences PharMingen). B cells were detected
using mAb B220 to detect CD45R (Caltag, Towcester,
UK) and T cells were detected using mAb 17A2 to detect
CD3 (Cambridge Bioscience, Cambridge, UK). For light
microscopy, following the addition of primary antibodies,
biotin-conjugated species-specific secondary antibodies
(Stratech, Soham, UK) were applied followed by alkaline
phosphatase coupled to the avidin/biotin complex (Vector
Laboratories, Peterborough, UK). Vector Red (Vector
Laboratories) was used as a substrate and sections were
counterstained with haematoxylin to distinguish cell
nuclei. For fluorescent microscopy, following the addition
of primary antibody, species-specific secondary antibodies
coupled to Alexa Fluor 488 (green) or Alexa Fluor 594
(red) dyes (Invitrogen, Paisley, UK) were used. Sections
were mounted in fluorescent mounting medium (Dako-
Cytomation, Ely, UK) and examined using a Zeiss LSM5
confocal microscope (Zeiss, Welwyn Garden City, UK).
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Quantitative real-time PCR analysis of mRNA expres-
sion
Total RNA was isolated from spleens and cells using
RNA-Bee (AMS Biotechnology, Oxfordshire, UK) fol-
lowed by treatment with DNase I (Ambion, Warrington,
UK). First-strand cDNA synthesis was performed using
1 lg of total RNA and the First-Strand cDNA Synthesis
kit (GE Healthcare Life Sciences, Little Chalfont, UK) as
described by the manufacturer. PCR amplification reac-
tions were performed using the Platinum-SYBR Green
qPCR SuperMix-UDG kit (Life Technologies, Paisley,
UK) and the Stratagene Mx3000P real-time quantitative
PCR system (Life Technologies). All quantitative PCR
primers used were designed using PRIMER3 software23 and
their details are provided in the Supporting information
(Table S1). The cycle threshold values were determined
using MXPRO software (Stratagene) and normalized to the
value of Actb or Hprt.
Microarray analyses of microRNA expression
RNA prepared from four mice per group was split into
two groups of two, and each group of two spleens was
pooled. These RNA pools were then analysed in parallel
as described below using Affymetrix and Exiqon microR-
NA expression arrays.
For Affymetrix, 2 lg of each RNA sample, prepared as
above, was hybridized to Affymetrix GeneChip miRNA
2.0 expression arrays (Affymetrix, Santa Clara, CA). First
the quality of the total RNA was verified by an Agilent
2100 Bioanalyzer profile (Agilent Technologies, Inc., Santa
Clara, CA). Microarray analysis was performed by Edin-
burgh Genomics (University of Edinburgh, UK) using Af-
fymetrix systems and reagents. Hybridization probes were
generated using the Ambion WT labelling kit and 500 ng
of RNA. Signal intensities were measured using a Gene-
Chip Scanner 3000 7G and CEL files were generated using
GeneChip Command Console software (AGCC). Data
were background corrected and normalized by robust
multi-array analysis using the EXIMIR package in R/Bio-
conductor.24
For Exiqon, 5 lg of each RNA sample was sent to Exi-
qon (Denmark) for quality analysis and subsequent micr-
oRNA microarray analysis. The quality of the total RNA
was verified by an Agilent 2100 Bioanalyzer profile. A
750-ng subsample of total RNA from both sample and
reference was labelled with Hy3TM and Hy5TM fluorescent
label, respectively, using the miRCURY LNATM microR-
NA Hi-Power Labeling Kit, Hy3TM/Hy5TM (Exiqon, Ved-
baek, Denmark) following the procedure described by the
manufacturer. The Hy3TM-labelled samples and a Hy5TM-
labelled reference RNA sample were mixed pair-wise and
hybridized to the miRCURY LNATM microRNA Array
6th GEN (Exiqon), which contains capture probes target-
ing all microRNAs for human, mouse or rat registered in
the miRBASE 16.0. The hybridization was performed
according to the miRCURY LNATM microRNA Array
Instruction manual using a Tecan HS4800TM hybridiza-
tion station (Tecan, Ma¨nnedorf, Switzerland). The miR-
CURY LNATM microRNA Array slides were scanned
using the Agilent G2565BA Microarray Scanner System
and the image analysis was carried out using the IMA-
GENE 9 (miRCURY LNATM microRNA Array Analysis
Software; Exiqon). The quantified signals were back-
ground corrected (Normexp with offset value 10)25 and
normalized using the global Lowess (LOcally WEighted
Scatterplot Smoothing) regression algorithm.
Differentially expressed microRNAs were determined
using the LIMMA package in R/Bioconductor.26 All raw
microarray data (CEL files) are deposited in the Gene
Expression Omnibus (GEO) under the following acces-
sion number: GSE55722. (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE55722).
microRNA Northern blot analysis
The expression profiles of selected microRNAs identified
by the microarray analyses (above) were validated by
microRNA Northern blot analysis. RNA was separated by
15% polyacrylamide TBE–urea gel (Criterion; Bio-Rad,
Hemel Hempstead, UK) electrophoresis at 125 V for
90 min and visualized using SybrGold nucleic acid dye
(Life Technologies). RNA was transferred to a nylon
membrane (Amersham Hybond-NX; GE Healthcare Life
Sciences) by semi-dry transfer at 220 mA for 1 hr.
RNA was then cross-linked to the membrane using
1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydro-
chloride cross-linking solution according to the protocol
described by Pall and Hamilton.27 For detection of
specific microRNA molecules, membranes were pre-
hybridized with ULTRAhyb Oligo buffer (Ambion) at 42°
for a least 2 hr and then incubated overnight at 42° with
complementary radiolabelled locked nucleic acid (LNA)
-modified oligonucleotides in ULTRAhyb Oligo buffer
(Ambion). LNA-modified oligonucleotides were obtained
from Exiqon with LNA nucleotides placed every three nu-
cleotides (see Supporting information; Table S2). Oligo-
nucleotides were radiolabelled at the 50 end with [c-32P]
ATP using a mirVana probe and marker kit (Ambion)
according to manufacturer’s protocol. After removal of
unbound oligonucleotide, membranes were wrapped in
saran wrap, placed in an exposure cassette and exposed
to autoradiograph film at 80° in the presence of a max-
imum sensitivity intensifying screen for between 4 and
24 hr. Autoradiographs were developed using a Konica
SRX-101A X-ograph machine. Membranes were routinely
subjected to a series of washes and exposures to a final
stringency of 01 9 SSC, 01% SDS and 60°. To strip
bound LNA-modified oligonucleotides, membranes were
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washed in boiling 01 9 SSC and checked for residual
signal by exposure to autoradiograph film. Membranes
were then re-probed as appropriate for either other mi-
croRNAs of interest or for U6-snRNA as a loading con-
trol. To quantify hybridized radiolabelled nucleic acid
after microRNA Northern blot analysis, membranes were
exposed to phosphorimager screens at room temperature
for the required length of time. For quantification screens
were scanned using a Typhoon FLA 7000 system (GE
Healthcare Life Sciences) and data were analysed using IM-
AGEQUANT TL software (GE Healthcare Life Sciences).
Cell culture
The established FDC-like cell line, FL-YB28 was used. This
cell line was originally derived from the popliteal lymph
nodes of immunized BALB/c mice as described previ-
ously.28 FL-YB cells were cultivated in a 1 : 1 mixture of
Dulbecco’s modified Eagle’s medium and RPMI-1640
media (Life Technologies) supplemented with 10%
heat-inactivated fetal calf serum (Life Technologies), 19
penicillin : streptomycin and 50 lM 2-mercaptoethanol
either with or without 5 ng/ml tumour necrosis factor-a
(TNF-a; PeproTech, Rocky Hill, NJ). Cells were plated at
a density of 5 9 104 viable cells/well in a six-well tissue
culture-treated plate (Corning Life Sciences, Amsterdam,
the Netherlands). The macrophage-like RAW 264.7 cell
line29 was cultured in RPMI-1640 supplemented with 5%
fetal calf serum and 19 penicillin : streptomycin. Cell
viability was determined using the CyQUANT Direct Cell
Proliferation Assay Kit (Life Technologies) according to
the manufacturer’s instructions. Briefly, this assay is based
on the assessment of both DNA content and membrane
integrity. The kit comprises a fluorescent live cell-perme-
able nucleic acid dye in combination with a background
suppression dye. The masking dye blocks the staining of
dead cells and those with compromised membranes
enabling only healthy cells to be stained allowing assess-
ment of cell growth, cell viability or compound toxicity.
Inhibition of specific microRNAs in FL-YB cells and
administration of specific microRNA mimmics
FL-YB cells were transfected using lipofectamine 2000
(Life Technologies) according to the manufacturer’s pro-
tocol. Briefly, FL-YB cells were plated in six-well or
96-well tissue culture plates at a density of 4 9 105 cells/
ml, stimulated with 5 ng/ml TNF-a and incubated
overnight at 37°. The medium was then removed and
replaced with 1 ml/well or 50 ll/well (for six-well or
96-well plates, respectively) of complete media without
antibiotics or TNF-a. An appropriate volume of transfec-
tion mixture containing the relevant nucleic acid was
added to each well of cells and incubated at 37° for 4 hr.
The transfection medium was then diluted with 29
volumes of complete media and incubated for a further
2 hr before being replaced with complete media plus
5 ng/ml TNF-a. Levels of specific microRNAs were
depleted by transfection of cells with 100 nM of LNA-
modified DNA oligonucleotide (Exiqon) with the comple-
mentary sequence to the microRNA being targeted (Table
S2). Levels of specific microRNA were elevated in cells by
transfection of cells with 30 nM of mirVana microRNA
mimics (Ambion) (see Supporting information; Table
S3). Cells were harvested 24 hr later and effects on micr-
oRNA and mRNA expression were compared.
Statistical analyses
Data are presented as mean  SD. Unless otherwise indi-
cated, differences between groups were statistically com-
pared using Student’s t-test.
Results
Effect of LTbR-blockade on FDC status in the spleen
Constitutive LTbR-mediated stimulation is required to
maintain the microarchitecture of secondary lymphoid
organs such as the spleen and lymph nodes.12,13,30,31 For
example temporary blockade of LTbR-signalling by treat-
ment of mice with soluble LTbR-Ig22 rapidly de-differen-
tiates FDC,12,13 and this approach was used here to
attempt to identify microRNAs that were potentially
expressed in LTbR-signalling-dependent cell populations
in the spleen such as FDC (Fig. 1). Immunohistochemical
analysis of the spleens of LTbR-treated mice confirmed
that within 2 days of treatment of WT mice with
LTbR-Ig the expression of CR1 (CD35) and MFGE8 by
FDC was dramatically reduced (Fig. 1). CR1- and
MFGE8-expressing FDC were undetectable in the spleens
of LTb/ mice, and as anticipated, in the spleens of WT
mice by 14 days after treatment with LTbR-Ig (Fig. 1a).
Real-time quantitative PCR analysis confirmed that the
expression of Mfge8 mRNA was also significantly reduced
in the spleens of FDC-deficient LTbR-Ig-treated WT mice
and LTb/ mice (Fig. 1b).
Expression of the chemokine CXCL13 by FDC is
important for inducing the migration of CXCR5-express-
ing B cells into the FDC-containing B-cell follicles.10 In
the absence of FDC, the expression of Cxcl13 mRNA was
significantly reduced in the spleens of LTbR-treated mice
(Fig. 1b) and coincided with an increasing failure to form
organized B-cell follicles at the later times following treat-
ment. By 14 days after LTbR-treatment the B cells were
situated in a continuous ring surrounding the T-cell
zones11 (Fig. 1c). Fibroblastic reticular cells, in contrast to
FDC, are stromal cells situated in the T-cell zones of sec-
ondary lymphoid organs and express high levels of cyto-
kines and chemokines such as CCL19 which attract T
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cells and mononuclear phagocytes.32 The expression of
Ccl19 was not significantly affected by LTbR-blockade
(Fig. 1b).
Effect of LTbR-blockade on microRNA expression in
the spleen
Next, RNA was isolated from the spleens of LTb/ mice
and WT mice 0, 2 and 14 days after treatment with
LTbR-Ig (four mice per group) and microRNA expres-
sion levels were compared between groups using both
Affymetrix and Exiqon microRNA microarrays. Two
different microarray platforms were chosen because
considerable variation can exist between different
platforms.33,34 Data were normalized and the microRNAs
that displayed the largest reduction in expression in the
LTb/ spleens when compared with WT controls on the
EXIQON platform were identified (Table 1). Six of these
20 microRNAs were also among the most reduced
microRNAs identified on the Affymetrix platform
(Table 2). Furthermore, each of these microRNAs showed
a dramatic reduction in their expression levels in the
spleen following LTbR-blockade (Tables 1 and 2).
The effects of LTbR-Ig-treatment on the expression lev-
els of three of the microRNAs identified above (mmu-
miR-100-5p, mmu-miR-138-5p and mmu-miR-2137)
were then compared by microRNA Northern blot analy-
sis. These three microRNAs were selected because they
displayed the most consistent effects after LTbR-blockade
across all samples and on each microarray platform.
MicroRNA Northern blot analysis confirmed that the
expression levels of each of these microRNAs was reduced
in the spleens of LTbR-Ig-treated and LTb/ mice when
compared with WT controls (Fig. 2).
Expression of microRNAs by FL-YB cells
Although effects on other LTbR-dependent cell popula-
tions cannot be excluded,30,35 data above suggest that
mmu-miR-100-5p, mmu-miR-138-59-5p and mmu-miR-
2137 are potential FDC-associated microRNAs because
their expression in the spleen was reduced by 2 days after
LTbR-blockade coincident with the rapid de-differentia-
tion of FDC. We therefore sought to determine whether
these microRNAs were expressed by FDC. The isolation
of highly purified FDC from secondary lymphoid tissues
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Figure 1. Effect of lymphotoxin b receptor
(LTbR) -blockade on follicular dendritic cells
(FDC) in the spleen. (a) Immunohistochemical
analysis of CR1/CD35 (upper panels, red) and
MFGE8 (lower panels, red) by FDC in the
spleens of LTb/ mice and wild-type (WT)
mice given a single intraperitoneal injection
with LTbR-Ig. Sections were counterstained
with haematoxylin (blue). (b) Quantitative
real-time reverse transcription-PCR analysis of
the effect of LTbR-blockade on Mfge8, Cxcl13
and Ccl19 expression in the spleen. (c) Immu-
nofluorescent analysis of the distribution of
T cells (CD3+ cells, green) and B cells (B220+
cells, red) in the spleens of LTb/ mice or
WT mice given a single intraperitoneal injec-
tion with LTbR-Ig. Dpi, day post-injection
with LTbR. Dotted lines indicate the bound-
aries of the B-cell areas. T, location of T-cell
zone. Data are derived from spleens from four
mice from each group.
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is however problematic. Difficulties include: lack of truly
FDC-specific cell markers, contamination with other cell
types such as B cells with which they form tight clusters;
contamination with macrophages, which can express high
levels of MFGE8, a typical marker used to identify
FDC;1,8,36 their low numbers within secondary lymphoid
organs when compared with other cell populations; and
their fastidious in vitro cultivation conditions that result
from the FDC’s requirement for constant LTbR stimula-
tion to maintain the differentiated state.12,13 Therefore, to
investigate the potential roles of mmu-miR-100-5p,
mmu-miR-138-5p and mmu-miR-2137 in FDC, a murine
FDC-like cell line, FL-YB, established from the popliteal
lymph nodes of immunized BALB/c mice was used.1,9,28,37
Factors such as LTbR- and TNF-a-mediated signalling,
which maintain FDC in their differentiated state in vivo,12
are also important for the proliferation of FL-YB cells.9,28
Consistent with previous data,28 quantitative real-time
PCR analysis confirmed that FL-YB cells expressed signifi-
cant levels of FDC-associated genes including Mfge8, Ltbr
(which encodes LTbR), Prnp (which encodes the prion
protein, PrPC)38 and Vcam1 (which encodes vascular cell
adhesion molecule 1)39 when compared with the macro-
phage RAW 264.7 cell line (Fig. 3).
RNA was isolated from FL-YB cells at intervals follow-
ing TNF-a stimulation and the expression of mmu-miR-
100-5p, mmu-miR-138-5p and mmu-miR-2137 compared
by microRNA Northern blot analysis. Expression of
mmu-miR-100-5p, mmu-miR-138-5p and mmu-miR-
2137 was detected in FL-YB cells (Fig. 4). Although subtle
variations in the expression levels of these microRNAs
were evident, each microRNA was expressed by the FL-
YB cells up to at least 96 hr after cultivation.
Effect of transient mmu-miR-100-5p inhibition on
gene expression by FL-YB cells
We next used four of the many computational algorithms
that have been developed to aid the identification of
likely mircroRNA target genes: DIANA micro-T (http://
diana.cslab.ece.ntua.gr/microT/); miRNA.org (http://www.
microrna.org/microrna/home.do); miRDB (http://mirdb.
org/miRDB/); RNA22 (http://cbcsrv.watson.ibm.com/
rna22.html). For possibly enhancing our chances of pre-
dicting genuine targets, we required that genes were pre-
dicted as a potential target for at least two out of three
microRNAs, by a minimum of three of the bioinformatics
Table 1. Top 20 down-regulated microRNAs in the spleen after lym-
photoxin b receptor (LTbR) -blockade identified by analysis on Exi-
qon microRNA microarrays
MicroRNA
LTbR-Ig (dpi)1
LTb/0 2 14
mmu-miR-100 100 082 068 027
mmu-miR-592* 100 066 056 029
mmu-miR-2137 100 091 062 034
mmu-miR-3102* 100 082 070 034
mmu-miR-762 100 072 065 035
mmu-miR-33 100 157 086 036
mmu-miR-138 100 097 059 038
mmu-miR-3090* 100 086 075 040
mmu-miR-487b 100 110 112 041
mmu-miR-2861 100 081 063 042
mmu-miR-1894-3p 100 073 068 043
mmu-miR-25* 100 069 065 044
mmu-miR-32 100 118 093 046
mmu-miR-187 100 083 054 047
mmu-miR-99a 100 083 076 047
mmu-miR-10b 100 078 077 047
mmu-miR-101b 100 100 093 048
mmu-miR-711 100 094 076 048
mmu-miR-28 100 067 076 050
mmu-miR-151-5p 100 078 076 051
MicroRNAs in bold type indicate those also identified using Affyme-
trix microRNA microarrays.
1Fold-change in expression level when compared with untreated
wild-type mice (d 0). Dpi, day post intraperitoneal injection with
LTbR-Ig.
Table 2. Top 20 down-regulated microRNAs in the spleen after lym-
photoxin b receptor (LTbR) -blockade identified by analysis on
Affymetrix microRNA microarrays
MicroRNA
LTbR-Ig (dpi)1
LTb/0 2 14
mmu-miR-708 100 078 064 020
mmu-miR-138 100 098 048 036
mmu-miR-2137 100 085 057 041
mmu-miR-187 100 093 052 046
mmu-miR-466h 100 102 143 049
mmu-miR-1893 100 080 066 050
mmu-miR-762 100 076 059 050
mmu-miR-100 100 078 072 053
mmu-miR-1224 100 062 061 054
mmu-miR-1937a 100 092 079 056
mmu-miR-139-3p 100 120 077 056
mmu-miR-1894-3p 100 066 069 057
mmu-miR-1937b 100 084 082 058
mmu-miR-2133 100 099 063 060
mmu-miR-151-3p 100 084 073 061
mmu-miR-193b 100 110 066 062
mmu-miR-1959 100 059 068 063
mmu-miR-466f 100 120 112 066
mmu-miR-455 100 097 094 067
mmu-miR-19a 100 130 145 067
MicroRNAs in bold type indicate those also identified using Exiqon
microRNA microarrays.
1Fold-change in expression level when compared with untreated
wild-type mice (d 0). Dpi, day post intraperitoneal injection with
LTbR-Ig.
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tools. However, at this level of stringency, no potential
target genes were predicted for any of these three microR-
NAs. Consequently, using the FL-YB cells we sought to
determine the effects of transient microRNA inhibition
on the expression of certain key genes expressed by FDC
which have been shown to influence the GC response: Il6
(which encodes IL-6),40,41 Ptgs1/2 (which encodes cyclo-
oxygenase 2)9 and Tlr4 (which encodes Toll-like receptor
4; TLR4).3,42
To deplete the available pools of specific microRNAs,
FL-YB cells were transfected with anti-sense LNAs directed
against mmu-miR-100-5p, mmu-miR-138-5p or mmu-
miR-2137. Conversely, to increase levels of these microR-
NAs the cells were transfected with specific microRNA
mimics. MicroRNA Northern blot analysis confirmed that
each anti-sense LNA specifically inhibited the expression
of the target microRNA by > 80%, whereas transfection
with the microRNA mimics increased the levels of the cor-
responding microRNAs by at least sevenfold (Fig. 5).
Transfection of the FL-YB cells with these reagents had no
observable effect on cell viability (data not shown).
Quantitative real-time PCR analysis showed that the
specific inhibition of mmu-miR-100-5p significantly
enhanced the expression of three genes Il6, Ptgs1/2 and
Tlr4 mRNA (Fig. 6a), while elevated levels of mmu-miR-
100-5p did not affect their expression. In contrast, manip-
ulating levels of mmu-mir-138-5p or mmu-miR-2137 did
not significantly influence the expression of these three
genes in FL-YB cells (Fig. 6a). Specific inhibition of
mmu-miR-100-5p
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Figure 2. Effect of lymphotoxin b receptor (LTbR) -blockade on
microRNA expression in the spleen. (a) MicroRNA Northern blot
analysis of the expression of mmu-miR-100-5p, mmu-miR-138-5p
and mmu-miR-2137 in the spleens of LTb/ mice and wild-type
(WT) mice given a single intraperitoneal injection with LTbR-Ig. U6
snRNA was used as a loading control. (b) Comparison of the relative
expression levels of each microRNA. On each histogram the relative
expression levels of each microRNA derived from analysis on Exiqon
microRNA microarrays (solid bars), Affymetrix microRNA micro-
arrays (open bars), and phosphoimager quantification of the micro-
RNA Northern blot membranes (densitometry, hatched bars) are
shown. Expression levels are normalized so the mean level in
untreated WT mice was 10. For each data point, spleens from four
mice from each group were pooled into two groups of two.
FL-YB
P < 3×10–9
P < 1×10–6
P < 3×10–8
P < 1×10–5
1·4
1·2
1·0
Mfge8 Ltbr Prnp Vcam1
0·8
0·6
0·4
0·2
0R
el
at
iv
e 
m
R
N
A 
ex
pr
es
sio
n 
le
ve
l RAW 264·7
Figure 3. Comparison of Ltbr, Mfge8, Prnp and Vcam1 expression
by follicular dendritic cell (FDC) -like cell line FL-YB and the mac-
rophage-like cell line RAW 264.7. Cells were harvested 48 hr after
cultivation and RNA was extracted. Quantitative real-time reverse
transcription-PCR analysis confirmed that FL-YB cells expressed
Ltbr, Mfge8, Prnp and Vcam1 highly when compared with RAW
264.7 cells. For each gene in each cell, expression levels were normal-
ized to the expression level of Hprt. Data are representative of four
independent experiments. Significant differences between samples
were determined by Student’s t-test.
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Figure 4. Analysis of microRNA expression in FL-YB cells. Micro-
RNA Northern blot analysis confirmed that FL-YB cells expressed
mmu-miR-100-5p, mmu-miR-138-5p and mmu-miR-2137.
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mmu-miR-100-5p did not affect the expression of certain
other FDC-associated genes such as Mfge8 (Fig. 6b), Ltbr
and Prnp (data not shown). Together, these data suggest
that mmu-miR-100-5p may indirectly modulate the
expression of Il6, Ptgs1/2 and Tlr4 mRNA in FL-YB cells.
Discussion
LTbR-blockade coincided with a dramatic decrease in the
expression of mmu-miR-100-5p, mmu-miR-138-5p and
mmu-miR-2137 in the spleen. FDC among other cell
populations in the spleen are critically dependent upon
continual LTbR stimulation to maintain them in their
differentiated state.12,13,30,31 Our data suggest that these
microRNAs are potentially expressed by FDC because
they were also expressed by the murine FDC-like cell line,
FL-YB. Specific inhibition of mmu-miR-100-5p in FL-YB
cells significantly enhanced their expression of Il6, Ptgs1/2
and Tlr4 mRNA, whereas inhibition of mmu-miR-138-5p
or mmu-miR-2137 did not. The expression of each of
these genes by FDC has been shown to play an important
role in regulating GC size and promoting high-affinity
antibody responses. MicroRNAs often act to ‘fine-tune’
the expression levels of their target genes. These data sug-
gest that mmu-miR-100-5p may plausibly play a role in
fine-tuning the expression of Il6, Ptgs1/2 and Tlr4 mRNA
by FDC during GC responses.
Inhibition of miR-100-5p in FL-Y cells caused a signifi-
cant increase in the expression of Il6 mRNA. B cells
within the secondary lymphoid tissues undergo GC reac-
tions to generate high-affinity antibodies with strong anti-
gen-specificity. In mice IL-6 plays a physiologically
relevant role in generating optimal GC reactions, and
promoting antibody responses, and somatic hypermuta-
tion and class-switch recombination in the immunoglob-
ulin genes of GC B cells.40,41 As immune complex-
activated FDC have been shown to produce IL-6,43 it is
plausible that mmu-miR-100-5p may play a role in con-
trol of the GC reaction by regulating their expression of
Il6 mRNA.
Toll-like receptor 4 binds bacterial lipopolysaccharide,
and signalling through this receptor promotes the expres-
sion of many pro-inflammatory genes. Oxidized phospho-
lipids, such as those generated during apoptosis, can also
act as TLR4 ligands and have been detected in FDC-con-
taining GC.3 Activated FDC in mice express TLR4, and
stimulation through this receptor either via lipopolysac-
charide or oxidized phospholipids up-regulates their
expression of adhesion molecules and Fc receptors.3,42
The absence of TLR4 expression on FDC led to a decrease
in both the number and size of GC, a reduced frequency
of FDC–GC B-cell interactions, reduced somatic hyper-
mutation and a decrease in high-affinity antibody
responses.3,42 Furthermore, the absence of TLR4 function
on FDC alters their transcriptome impairing their expres-
sion of Ltbr, the adhesion molecule gene Icam1 and cyto-
kine genes involved in the GC reaction and antibody
responses (ll6 and Il15).3 Data presented here suggest that
mmu-miR-100-5p indirectly down-regulates the expres-
sion of Tlr4 mRNA in FL-YB cells. Hence it is plausible
that the modulation of Tlr4 mRNA by mmu-miR-100-5p
in FDC may play an important role in regulating the GC
reaction. TLR4 signalling up-regulates IL-6, and aberrant
expression of both of these genes has been implicated in
some autoimmune diseases. Up-regulation of TLR4 can
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Figure 5. Confirmation of specific manipulation of microRNA
expression levels in FL-YB cells. To deplete (knock-down, KD)
microRNA levels, cells were transfected with anti-sense locked
nucleic acid (LNA) oligonucleotides specific for the target micro-
RNA. To elevate (EL) the level of specific microRNAs, cells were
transfected with double-stranded RNA mimics. The effects of these
manipulations on the expression levels of (a) mmu-miR-100-5p, (c)
mmu-miR-138-5p and (d) mmu-miR-2137 were analysed by micro-
RNA Northern blot analysis 24 hr later. (b) Representative phospho-
imager quantification of the microRNA Northern blot membranes of
the effects of these treatments on the relative expression levels of
mmu-miR-100-5p in FL-YB cells. Data were normalized to the
lipofectamine control. This analysis shows that the mmu-miR-100-
5p-specific LNA specifically inhibited the expression of the target
microRNA (mmu-miR-100-5p) by approximately fivefold and did
not affect the expression levels of mmu-miR-138-5p or mmu-miR-
2137. Transfection with a mmu-miR-100-59 double-stranded RNA
mimic, in contrast, specifically increased the expression of this
microRNA by approximately sevenfold. Data are representative of
four or more independent experiments.
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induce a lupus-like autoimmune disease in mice,44 and
expression of IL-6 is dysregulated in the serum and syno-
vial fluid of patients with rheumatoid arthritis.45 Further
experiments are now necessary to determine whether
mmu-miR-100-5p is expressed by FDC in vivo and acts
to fine-tune the expression of GC-related genes via mod-
ulation of Tlr4 mRNA.
During the GC reaction, B cells undergo somatic
hypermutation in the V regions of their immunoglobulin
genes. Those B cells with high antigen affinity are posi-
tively selected and receive survival signals by interactions
with FDC and follicular helper T cells, whereas those with
low affinity do not receive these stimuli and undergo
apoptosis. Data from the analysis of human46 and mouse9
FDC suggest that they express prostaglandin E2, which
may play an immunoregulatory role in the GC. For
example, its expression by FDC in association with follic-
ular helper T-cell-derived IL-21 plays a role in the nega-
tive selection of GC B cells.9 Cyclooxygenase 2 (encoded
by Ptgs2) converts arachidonic acid to prostaglandin H2,
which can then be subsequently converted into different
prostaglandins and prostacyclin.47 Inhibition of mmu-
miR-100-5p in FL-YB cells significantly increased their
expression of Ptgs1/2 mRNA, providing a further example
of how the expression of this microRNA may help to reg-
ulate the GC reaction.
Although data presented here suggest that mmu-miR-
100-5p modulates the expression of Il6, Ptgs1/2 and Tlr4
mRNA, a range of target prediction algorithms failed to
identify any plausible target genes. Little is known of the
genes targeted by mmu-mir-100-5p, although predictions
from individual algorithms include the gene encoding the
mammalian target of rapamysin (Mtor) where this micr-
oRNA is considered to play a role in neovascularization
in endothelial vascular smooth muscle cells in mice48 and
certain tumours in humans.49 In the current study the
expression level of Mtor was unchanged in the spleen
after LTbR-blockade and was undetectable in FL-YB cells
(data not shown), suggesting that the effects on gene
expression described above were unlikely to be due to the
targeting of Mtor mRNA by mmu-mir-100-5p. No likely
binding sites for mmu-miR-100-5p were identified in the
sequences of Il6, Ptgs1/2 and Tlr4, suggesting that this
microRNA may be indirectly influencing the expression
of these genes by targeting another gene upstream of their
expression.
Our data do not exclude the possibility that mmu-miR-
100-5p may also modulate gene expression in other
LTbR-dependent cell populations within secondary lym-
phoid tissues.30,31,35 Data elsewhere show that effects of
LTbR-blockade on the presence of classical dendritic cells
in the spleen were noted 10–15 days after treatment35 and
P < 0·01
ll6 Mfge8
NS
Ptgs
Tlr4
2·5
(a) (b)
2
1·5
1
0·5
0
2·5
2
1·5
1
0·5
0
2·5
2
1·5
1
0·5
0
2·5
3R
el
at
ive
 m
R
N
A 
ex
pr
es
sio
n 
le
ve
l
R
el
at
ive
 m
R
N
A
ex
pr
es
sio
n 
le
ve
l
2
1·5
1
0·5
0
P < 0·04
P < 0·05
lip
of
e
ct
am
in
e 
on
ly
m
m
u
-m
iR
-1
00
-5
p-
KD
m
m
u
-m
iR
-1
38
-5
p-
KD
m
m
u
-m
iR
-2
13
7-
KD
m
m
u
-m
iR
-2
13
7-
EL
m
m
u
-m
iR
-1
00
-5
p-
EL
lip
of
e
ct
am
in
e 
on
ly
m
m
u
-m
iR
-1
00
-5
p-
KD
m
m
u
-m
iR
-1
38
-5
p-
KD
m
m
u
-m
iR
-2
13
7-
KD
m
m
u
-m
iR
-2
13
7-
EL
m
m
u
-m
iR
-1
00
-5
p-
EL
Figure 6. Specific inhibition of mmu-miR-
100-5p enhances the expression of Il6, Ptgs1/2
and Tlr4 in FL-YB cells. To deplete (knock-
down, KD) microRNA levels, cells were trans-
fected with anti-sense locked nucleic acid
(LNA) oligonucleotides specific for the target
microRNA. To elevate (EL) the level of specific
microRNAs, cells were transfected with
double-stranded RNA mimics. RNA was
isolated 24 hr later and the effects of these
manipulations on the expression levels of (a)
Il6, Ptgs1/2, Tlr4 and (b) Mfge8 mRNA were
determined by quantitative real-time reverse
transcription-PCR analysis. Expression levels
were normalized to Actb and are presented
relative to the levels expressed in non-
transfected, lipofectamine-treated control cells.
Data are representative of three or more inde-
pendent experiments. Significant differences
between samples were determined by Student’s
t-test. NS, not significant.
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effects on high endothelial venules in lymph nodes were
evident 28 days after treatment.30 In the current study a
decrease in the expression of mmu-miR-100-5p was evi-
dent in the spleen as soon as 2 days following LTbR treat-
ment coincident with the rapid de-differentiation of FDC.
Furthermore, this microRNA was confirmed to be
expressed in the FDC-like cell line, FL-YB, and specific
inhibition of mmu-miR-100-5p in this cell line signifi-
cantly enhanced the expression of Il6, Ptgs1/2 and Tlr4
mRNA.
Currently nothing is known of the expression of
microRNAs by FDC. Similarly, nothing was known of the
effects of LTbR stimulation on microRNA expression in
the spleen. These data therefore provide a useful founda-
tion for the design of future studies aimed at determining
how LTbR stimulation modulates microRNA expression
in secondary lymphoid organs, and whether mmu-miR-
100-5p helps to modulate FDC function and the GC
response in vivo, for example by specifically manipulating
microRNA expression in FDC.
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